- The agrochemical company
Heranba Industries listed nearly 43.5% higher and was trading at ₹900 a piece, compared to the IPO issue price of ₹626-627. - The company's market value expanded to ₹3,678 crore after the listing.
- Heranba is one of the leading domestic producers of synthetic pyrethroids like cypermethrin, alphacypermethrin, deltamethrin, permethrin, lambda-cyhalothrin.
- Check out the latest news and updates on Business Insider.
Within minutes after listing, the shares of Heranba gained 2.14% of their value and were trading at ₹919.25 apiece at 10:05 am in an otherwise tepid market. The company's market value expanded to ₹3,678 crore after the listing.
Heranba is one of the leading domestic producers of synthetic pyrethroids like cypermethrin, alphacypermethrin, deltamethrin, permethrin, lambda-cyhalothrin.
The bumper listing was already on the cards!
Heranba's public issue had received positive reviews from top brokerages, and the grey market was also ready to pay a hefty premium for its shares.
"Company return ratios are superior to peers (ROE is above 30%). Company has a strong financial position and has been generating positive cash flow. We expect a good listing for the company," said Keshav Lahoti, associate equity analyst at Angel Broking, in a post IPO note.
The IPO garnered a massive response from investors and was oversubscribed nearly 88 times — making it the second most successful IPO in terms of subscription in 2021. According to data from the stock-exchanges, the issue received bids for 58.15 crore equity shares against an offer size of 69.81 lakh shares.
The shares were commanding a premium of ₹260-270 in the grey market over the set price band of ₹626-627 per share, ahead of the listing. However, the grey market is not an official measure of the market premium.
SEE ALSO: